Genetics of multiple myeloma: another heterogeneity level?, Blood, vol.125, issue.12, pp.1870-1876, 2015. ,
DOI : 10.1182/blood-2014-10-567370
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review, Leukemia, vol.91, issue.12, pp.2210-2221, 2009. ,
DOI : 10.1016/j.beha.2007.08.004
The genetic architecture of multiple myeloma, Nature Reviews Cancer, vol.214, issue.5, pp.335-348, 2012. ,
DOI : 10.1038/nrc3257
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2, Blood, vol.117, issue.18, pp.4696-4700, 2011. ,
DOI : 10.1182/blood-2010-10-300970
Interpretation of cytogenetic results in multiple myeloma for clinical practice, Blood Cancer J, vol.5, p.365, 2015. ,
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma, Blood Cancer Journal, vol.122, issue.10, p.363, 2015. ,
DOI : 10.1038/bcj.2013.34
MEK inhibitors as a chemotherapeutic intervention in multiple myeloma, Blood Cancer Journal, vol.9, issue.3, p.105, 2013. ,
DOI : 10.1182/blood-2010-04-278788
Update on risk stratification and treatment of newly diagnosed multiple myeloma, International Journal of Hematology, vol.28, issue.19, pp.310-320, 2011. ,
DOI : 10.1007/s12185-011-0947-z
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013, Mayo Clinic Proceedings, vol.88, issue.4, pp.360-376, 2013. ,
DOI : 10.1016/j.mayocp.2013.01.019
Initial genome sequencing and analysis of multiple myeloma, Nature, vol.47, issue.7339, pp.467-472, 2011. ,
DOI : 10.1038/nature09837
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma, Blood, vol.120, issue.5, pp.1077-1086, 2012. ,
DOI : 10.1182/blood-2012-03-412981
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma, Nature Communications, vol.173, p.2997, 2014. ,
DOI : 10.1038/ncomms3997
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy, Cancer Cell, vol.25, issue.1, pp.91-101, 2014. ,
DOI : 10.1016/j.ccr.2013.12.015
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group, Journal of Clinical Oncology, vol.33, issue.26, pp.2863-2869, 2015. ,
DOI : 10.1200/JCO.2015.61.2267
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol, Haematologica, vol.100, issue.2, pp.214-222, 2015. ,
DOI : 10.3324/haematol.2014.113381
Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture, Leukemia, vol.93, issue.9, pp.1820-1825, 2013. ,
DOI : 10.1056/NEJMoa0810069
Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, issue.22, pp.3616-3627, 2013. ,
DOI : 10.1182/blood-2013-08-518886
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, vol.82, issue.2, pp.241-247, 2014. ,
DOI : 10.1038/leu.2013.336
Clinical Grade ???SNaPshot??? Genetic Mutation Profiling in Multiple Myeloma, EBioMedicine, vol.2, issue.1, pp.71-73, 2015. ,
DOI : 10.1016/j.ebiom.2014.11.008
P) in -17p high risk disease, British Journal of Haematology, vol.120, issue.4, pp.507-510, 2015. ,
DOI : 10.1111/bjh.13171
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells, Blood, vol.121, issue.17, pp.3413-3419, 2013. ,
DOI : 10.1182/blood-2012-12-471888
An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, pp.56-65, 2012. ,
Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, vol.26, issue.5, pp.589-595, 2010. ,
DOI : 10.1093/bioinformatics/btp698
BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, vol.26, issue.6, pp.841-842, 2010. ,
DOI : 10.1093/bioinformatics/btq033
COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Research, vol.43, issue.D1, pp.805-811, 2015. ,
DOI : 10.1093/nar/gku1075
Mutational Processes Molding the Genomes of 21 Breast Cancers, Cell, vol.149, issue.5, pp.979-993, 2012. ,
DOI : 10.1016/j.cell.2012.04.024
In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities, Cancer Cell, vol.27, issue.3, pp.382-396, 2015. ,
DOI : 10.1016/j.ccell.2015.02.007
Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis, The Journal of Cell Biology, vol.65, issue.5, pp.831-846, 2008. ,
DOI : 10.1038/nrn1370
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing, Proceedings of the National Academy of Sciences, vol.109, issue.10, pp.3879-3884, 2012. ,
DOI : 10.1073/pnas.1121343109
Nebulin The Nebulous, Multifunctional Giant of Striated Muscle, Trends in Cardiovascular Medicine, vol.13, issue.5, pp.195-201, 2003. ,
DOI : 10.1016/S1050-1738(03)00076-8
Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, vol.31, issue.7457, pp.214-218, 2013. ,
DOI : 10.1038/nature12213
Prognostic Significance of Copy-Number Alterations in Multiple Myeloma, Journal of Clinical Oncology, vol.27, issue.27 ,
DOI : 10.1200/JCO.2008.20.6136
Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells, British Journal of Haematology, vol.230, issue.4, pp.523-528, 1991. ,
DOI : 10.1111/j.1365-2141.1991.tb08620.x
Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo, Genome Biology, vol.15, issue.5 ,
DOI : 10.1089/hum.2010.068
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma, Journal of Clinical Oncology, vol.33, issue.33, pp.3911-3920, 2015. ,
DOI : 10.1200/JCO.2014.59.1503
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma, Blood, vol.123, issue.20, pp.3073-3079, 2014. ,
DOI : 10.1182/blood-2014-01-550020
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, The Lancet Oncology, vol.15, issue.12, pp.538-548, 2014. ,
DOI : 10.1016/S1470-2045(14)70442-5
Differential and limited expression of mutant alleles in multiple myeloma, Blood, vol.124, issue.20, pp.3110-3117, 2014. ,
DOI : 10.1182/blood-2014-04-569327